This topic contains a solution. Click here to go to the answer

Author Question: A patient has been using latanoprost (Xalatan) ophthalmic drops. The patient tells the nurse, My ... (Read 87 times)

cabate

  • Hero Member
  • *****
  • Posts: 537
A patient has been using latanoprost (Xalatan) ophthalmic drops. The patient tells the nurse, My eyes used to be greenish-brown, but now they're brown. What will the nurse do?
 
  a. Reassure the patient that this is a harmless side effect.
  b. Report this toxic effect to the patient's provider.
  c. Tell the patient that this indicates an increased risk of migraine headaches.
  d. Tell the patient that this effect will reverse when the medication is withdrawn.

Question 2

A patient with chronic myeloid leukemia (CML) begins treatment with imatinib (Gleevec). Which statement by the patient indicates understanding of this medication?
 
  a. Resistance to this drug may develop over time.
  b. The intensity of side effects is dose dependent.
  c. This drug does not have significant drug interactions.
  d. This drug must be given intravenously.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

milbourne11

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

ANS: A
Latanoprost can cause a harmless, heightened brown pigment of the iris that stops when the medication is discontinued but does not regress. It is not a sign of a toxic reaction. It does not indicate an increased risk of developing migraines. It will not reverse.

Answer to Question 2

ANS: A
Over time, resistance to imatinib may develop because the genes that code for BCR-ABL can mutate. Side effects of imatinib are not dose-dependent. Imatinib has significant drug interactions with several drugs. Imatinib is given orally.




cabate

  • Member
  • Posts: 537
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


coreycathey

  • Member
  • Posts: 333
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

For a complete list of videos, visit our video library